Der er identificeret fire metaboliske processer in vivo, hvoraf ingen udgjorde mere end 6, 5% af dosis, nemlig dealkylering, hydroxylering, dehydrogenering og benzisoxazolspaltning.
Four metabolic pathways have been identified in vivo, none of which accounted for more than 6.5% of the dose: dealkylation, hydroxylation, dehydrogenation, and benzisoxazole scission.